Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:

Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_3936_Библиотеки_им_академика_М_И_Перельмана

.pdf
Скачиваний:
0
Добавлен:
10.10.2026
Размер:
7 Мб
Скачать
☆
enlargement of internal iliac aneurysms treated by simple
proximal ligation is well recorded. Even small aneurysms,
less than 3 cm in diameter,may fail to completely thrombose
after proximal ligation alone (Nakajima et al. 2001). It is
currently accepted that the best open surgical procedure
involves the stitching of the branch vessel ostia from within
the aneurysm sac (endo-aneurysmorrhaphy) as well as
proximal ligation. This operation can be technically difficult,
and carries an appreciable mortality (5–10%) and should
probably bereserved for fit patients with symptoms related to
compression of adjacent structures (Parry et al. 2001).
The endovascular options include placement of a stent-
graft across the internal iliac origin after occlusion of the
outflow, packing of the entire aneurysm sac with multiple
thrombogenic coils or occlusion of both the inflow and
the outflow vessels (Parry et al. 2001; Fahrni et al. 2003;
Tsilimparis et al. 2009).
The simplest method of transcatheter intervention is the
placement ofan appropriatestent-graft, asdescribed abovefor
the common iliac segment, across the internal iliac ostium.
This technique is not dependent onthe presence of a proximal
neck and may be reserved for those cases with little or no
normal artery between the internal iliac ostium and the
aneurysm sac. The internal iliac artery bifurcation is cathe-
terised prior to stent insertion and the anterior and posterior
divisions blocked as proximally as possible with either plati-
numcoils orAmplatzer plugs(Fig. 7). Thismeans thatthe coil
diameter must becarefully chosento beoversized by1–2 mm
in order toavoid distal extension andbranch vessel occlusion.
The use offluid embolic materialin these circumstancesis not
advisable because of the risk of severe pelvic ischaemia and
potential damage to sensitive adjacent organs and nerves.
Where there is a well defined ‘proximal neck’ of internal
iliac main-stem leading into the aneurysm and suitable exit
Fig. 6 a This CTA shows a
5cmleft internal iliac aneurysm
and a small right internal iliac
aneurysm. b The 3D
reconstruction shows that there is
also a 2.8 cm aneurysm of the left
common iliac artery. c A10mm
Amplatzer plug has been placed
in the posterior division of the
left internal iliac and the tip of the
contralateral 6F sheath has been
placed in the origin of the left
anterior division prior to
deployment of a 12 mm plug
which will extrude into the main
trunk after release. d Deployment
of an Endurant stent-graft limb
(Medtronic) between the
proximal left common and
external iliac segments has
excluded both left iliac
aneurysms. There is no
backfilling via the plugged
internal iliac artery and the 4
radio-opaque markers are visible
on the two plugs
174 R. Jackson and J. Rose
https://t.me/med1917
vessels in terms of an anterior and a posterior divisional
branch, then selective occlusion of inflow and outflow
vessels will suffice. Appropriately oversized platinum coils
or plugs are used to block the internal iliac artery bifurca-
tion, taking care not to encroach on the distal branch ves-
sels. The ostium of the vessel is then plugged (Fig 7c).
If the aneurysm is large and complex with multiple small
outflow branches, it may prove impossible to safely occlude
these outflow vessels individually. In such cases it may be
possible to pack the aneurysm sac completely with a mixture
of coils, generally starting with larger coils and filling in the
residual spaces with medium and small coils. In exceptional
cases thrombin may be injected through the same catheter in
order to produce a more complete thrombotic effect. As an
alternative, Onyx may be used in the same manner as for
visceral artery aneurysms (described above in Sect. 2).
3.4.3 External Iliac Aneurysms
The external iliac segment is very rarely involved by ath-
eromatous aortoiliac aneurysms and is only occasionally
found as the site of an isolated iliac aneurysm. In general,
as for common iliac lesions, the endovascular treatment
consists of stent-graft insertion. Where there is no suitable
proximal neck in the external iliac, the proximal end of the
stent-graft may be placed in the common iliac.
Fig. 7 a An isolated, right internal iliac aneurysm was selectively
catheterised via a left femoral approach and a coil bundle created in the
distal trunk. b The aneurysm had a very short proximal neck and this
image shows a 12 mm Amplatzer plug immediately after deployment
in the ostium of the internal iliac. c Follow-up CTA at 6 months
confirmed complete exclusion of the internal iliac aneurysm sac. The
lower end of the Amplatzer plug is visible in the anterior sac.
Subsequent annual ultrasound follow-up has remained satisfactory
Fig. 8 a, b There is a 17 mm
false aneurysm arising from the
left brachial artery. c, d Under US
guidance a 21-G needle is
positioned within the false
aneurysm and thrombin injected
leading to immediate almost
complete thrombosis
Endovascular Repair of Iliac, Visceral and False Aneurysms 175
https://t.me/med1917
4 Femoral False Aneurysms
Requests to examine a painful expansile swelling in the groin
following femoral artery catheterisation are an extremely
familiar scenario in all ultrasound departments within hos-
pitals that provide an interventional vascular or cardiology
service. The diagnosis and subsequent management of
peripheral falseaneurysmshas beentaken overcompletely by
the radiologist during the last decade. In addition to ultra-
sound-guided compression, all the techniques described
previously inthis chapterhave beenused totreat femoralfalse
aneurysms. Without doubt, however, percutaneous thrombin
injection has been shown to be the quickest, most pain-free
and effective treatment. Success rates of over 90% are to be
expected with a single injection and complications are rare
(Morgan and Belli 2003; Hanson et al. 2008).
In most institutions thrombin injection is now the treat-
ment of choice for stable false aneurysms, which have failed
to resolve after 48 h of observation. Human thrombin
(Tisseel, Baxter, Glendale, CA, USA) is used at low doses,
usually less than 500 IU. Balloon protection is no longer
used. While femoral false aneurysms are by far the most
commonly encountered, other sites have also been treated
with percutaneous thrombin (Fig. 8).
5 Conclusion
This chapter has focussed on endovascular treatment for a
variety of aneurysms. Visceral and isolated iliac aneurysms
are relatively uncommon, but with the exception of common
iliac aneurysms they can be very challenging to treat by open
surgical methods. Although their incidence makes it highly
unlikely that firm evidence will ever be available from
randomised studies, it is clear that a variety of endovascular
therapies are now available which provide successful treat-
ment, at least in the medium term, while avoiding the
potential complications of difficult surgery. The use of
ultrasound compression and more recently percutaneous
thrombin injection has been a revolution in the management
of femoral, and other, false aneurysms occurring after
catheterisation, so that few of these patients now need to be
managed with open surgery.
References
Abath C, Andrade G, Cavalcanti D et al (2007) Complex renal artery
aneurysms: liquids or coils? Tech Vasc Interv Rad 10:299–307
Arepally A, Dagli M, Hofmann LV, Kim HS, Cooper M, Klein A
(2002) Treatment of splenic artery aneurysm with use of a stent-
graft. J Vasc Interv Radiol 13:631–633
Balderi A,Antonietti A, PedrazziniF et al(2011) Treatment ofa hepatic
artery aneurysm by endovascular exclusion using the multilayer
Cardiatis stent. Cardiovasc Interven Radiol 33:1282–1286
Bruce M, Yew-Ming K (2002) Endoluminal stent-graft repair of a
renal artery aneurysm. J Endovasc Ther 9:359–362
Brunkwall J, Hauksson H, Bengtsson H et al (1989) Solitary
aneurysms of the iliac arterial system: an estimate of their
frequency of occurrence. J Vasc Surg 10:381–384
Chemelli A, Beate H, Klocker J et al (2010) Endovascular repair of
isolated iliac artery aneurysms. J Endovasc Ther 17:492–503
Dave B, Sharma A, Kwolek C et al (2010) Percutaneous transcatheter
arterial embolization of inferior pancreatico-duodenal artery aneu-
rysms associated with celiac artery stenosis or occlusion. Catheter
Cardiovasc Interv 75:663–672
Dosluoglu HH, Dryjski ML, Harris LM (1999) Isolated iliac artery
aneurysms in patients with or without previous abdominal aortic
aneurysm repair. Am J Surg 178:129–132
Fahrni M, Lachat MM, Wildermuth S et al (2003) Endovascular
therapeutic options for isolated iliac aneurysms with a working
classification. Cardiovasc Intervent Radiol 26:443–447
Fankhauser GT, Stone WM, Naidu SG et al (2011) The minimally
invasive management of visceral artery aneurysms and pseudoan-
eurysms. J Vasc Surg 53:966–970
Ferreira M, Monteiro M, Lanziotti L (2010) Technical aspects and
midterm patency of iliac branched devices. J Vasc Surg 51:
545–550
Gabelmann A, Gorich J, Merkle EM (2002) Endovascular treatment of
visceral artery aneurysms. J Endovasc Ther 9:38–47
Grego FG, Lepidi S, Ragazzi R, Iurilli V, Stramana R, Deriu GP
(2003) Visceral artery aneurysms: a single center experience.
Cardiovasc Surg 11(1):19–25
Hanson JM, Atri M, Power N (2008) Ultrasound-guided thrombin
injection of iatrogenic groin pseudoaneurysm: doppler features and
technical tips. B J Radiol 81:154–163
Heestand G, Sher L, Lightfoote J, Palmer S, Mateo R, Singh G, Moser
J, Selby R, Genyk Y, Jabbour N (2003) Characteristics and
management of splenic artery aneurysm in liver transplant
candidates and recipients. The American Surg 69(11):933–940
Hislop SJ, Patel SA, Abt PL et al (2009) Therapy of renal artery
aneurysms in New York state: outcomes of patients undergoing
open and endovascular repair. Ann Vasc Surg 23:194–200
Hoffer EK, Nicholls SC, Fontaine AB et al (1999) Internal to external
iliac artery stent-graft: a new technique for vessel exclusion. J Vasc
Interv Radiol 10:1067–1073
Huang Y, Gloviczki P, Duncan A et al (2008) Common iliac artery
aneurysm: expansion rate and results of open surgical and
endovascular repair. J Vasc Surg 47:1203–1211
Ishimaru H, Murakami T, Matsuoka Y, Sakamoto I, Koshiishi T,
Hayashida M, Fujimoto T, Hayashi K (2004) N-butyl 2-cyanoac-
rylate injection via pancreatic collaterals to occlude splenic artery
distal to large splenic aneurysm after proximal coil embolization.
AJR 182:213–215
Jiang J, Ding X, Su Q et al (2011) Therapeutic management of
superior mesenteric artery aneurysms. J Vasc Surg 53:1619–1624
Kallamadi R, deMoya MA, Kalva SP (2009) Inferior pancreaticodu-
odenal artery aneurysms in association with celiac stenosis/
occlusion. Semin Interven Radiol 26:215–223
Kemmeter P, Bonnell B, Vander Kolk W, Griggs T, Van Erp J (2000)
Percutaneous thrombin injection of splanchnic artery aneurysms:
two case reports. J Vasc Interv Radiol 11:469–472
Kim BS, Do HM, Razavi M (2004) N-butyl cyanoacrylate glue
embolization of splenic artery aneurysms. J Vasc Interv Radiol
15:91–94
Klein GE, Szolar DH, Breinl E, Raith J, Schreyer HH (1997)
Endovascular treatment of renal artery aneurysms with
176 R. Jackson and J. Rose
https://t.me/med1917
conventional non-detachable microcoils and Guglielmi detachable
coils. Br J Urol 79(6):852–860
Lakin RO, Bena JF, Sarac TP et al (2011) The contemporary
management of splenic artery aneurysms. J Vasc Surg 53:958–965
Lupattelli T, Abubacker Z, Morgan R, Belli AM (2003) Embolization
of a renal artery aneurysm using ethylene vinyl alcohol copolymer
(Onyx). J Endovasc Ther 10:366–370
Manazer JR, Monzon JR, Dietz PA, Moglia R, Gold M (2003)
Treatment of pancreatic pseudoaneurysm with percutaneous trans-
abdominal thrombin injection. J Vasc Surg 38:600–602
Marone EM, Mascia D, Kahlberg A et al (2011) Is open repair still the
gold standard in visceral artery aneurysm management? Ann Vasc
Surg 25:936–946
Matsumoto K, Matsubara K, Watada S et al (2004) (2004) Surgical
and endovascular procedures for treating isolated iliac artery
aneurysms: ten-year experience. World J Surg 28:797–800
McCready RA, Pairolero PC, Gilmore JC et al (1983) Isol iliac artery
aneurysms. Surg 93:688–693
Meyer C, Verrel F, Weyer G et al (2011) Endovascular management of
complex renal artery aneurysms using the mulitlayer stent.
Cardiovasc Interven Radiol 34:637–641
Morgan R, Belli AM (2003) Current treatment methods for postcath-
eterization pseudoaneurysms. J Vasc Interv Radiol 14:697–710
Nakajima T, Kawazoe K, Komoda K et al (2001) Failure of exclusion
of internal iliac artery aneurysms. J Vasc Surg 33:476–480
Owens CA, Yaghmai B, Aletich V, Benedetti E (2002) Coil
embolization of a wide-neck splenic artery aneurysm using a
remodelling technique. AJR 179:1327–1329
Parry DJ, Kessel D, Scott DJ (2001) Simplifying the internal iliac
artery aneurysm. Ann R Coll Surg Engl 83:302–308
Patel NV, Long GW, Cheema ZF et al (2009) Open vs endovascular
repair of isolated iliac artery aneurysms: a 12 year experience.
J Vasc Surg 49:1147–1153
Pilleul F, Dugougeat F (2002) Transcatheter embolization of
splanchnic aneurysms/pseudoaneurysms: early imaging allows
detection of incomplete procedure. J Comput Assist Tomogr
26(1):107–112
Richardson JW, Greenfield LJ (1988) Natural history and management
of iliac aneurysms. J Vasc Surg 8:165–171
Sahgal A, Veith FJ, Lipsitz E et al (2001) Diameter changes in isolated
iliac artery aneurysms 1 to 6 years after endovascular graft repair.
J Vasc Surg 33:289–284
Santilli SM,Wernsing SE,Lee ES (2000)Expansion rates and outcomes
for iliac artery aneurysms. J Vasc Surg 31(1 Pt 1):114–121
Sessa C, Tinelli G, Porcu P, Aubert A, Thony F, Magne JL (2004)
Treatmentof visceralartery aneurysms: description ofa retrospective
series of 42 aneurysms in 34 patients. Ann Vasc Surg 18(6):695–703
Shanley CJ, Shah NL, Messina LM (1996a) Common splanchnic
artery aneurysms: splenic, hepatic and coeliac. Ann Vasc Surg
10(3):315–322
ShanleyCJ, ShahNL, Messina LM(1996b)Uncommonsplanchnicartery
aneurysms: pancreatico-duodenal, gastroduodenal, superior mesen-
teric, inferior mesenteric and colic. Ann Vasc Surg 10(5):506–515
Sparrow P, Asquith J, Chalmers N (2003) Ultrasonic-guided percu-
taneous injection of pancreatic pseudoaneurysm with thrombin.
Cardiovasc Interven Radiol 26(3):312–315
Tsilimparis N, Alevizakos P, Yousefi S (2009) Treatment of internal
iliac artery aneurysms: single-centre experience. ANZ J Surg
79:258–264
Tulsyan N, Kashyap VS, Greenberg RK et al (2007) The endovascular
management of visceral artery aneurysms and pseudoaneurysms.
J Vasc Surg 45:276–283
Venturini M, Angeli E, Salvioni M, De Cobelli F, Trentin C, Carlucci
M, Staudacher C, Del Maschio A (2002) Hemorrhage from a right
hepatic artery pseudoaneurysm: endovascular treatment with a
coronary stent-graft. J Endovasc Ther 9:221–224
Ziegler P, Avgerinos E, Umscheid T et al (2007) Branched iliac
bifurcation: 6 years experience with endovascular preservation of
internal iliac artery flow. J Vasc Surg 46:204–210
Endovascular Repair of Iliac, Visceral and False Aneurysms 177
https://t.me/med1917
Dialysis Access Management
J. R. Asquith
Contents
1 Introduction.......................................................................... 179
2 Dialysis Line Insertion and Management......................... 179
2.1 Dialysis Line Insertion .......................................................... 179
2.2 Choice of Vein for Access: Conventional Central Veins.... 180
2.3 Optimal Catheter Position..................................................... 180
2.4 Alternative Dialysis Line Access Routes ............................. 180
2.5 Fibrin Sheath Formation ....................................................... 180
2.6 Catheter Repositioning .......................................................... 181
3 Management of Dialysis Fistulae and Grafts................... 182
3.1 Imaging of Dialysis Fistulae and Grafts............................... 182
3.2 Angioplasty of Dialysis Fistulae and Grafts ........................ 182
3.3 Angioplasty of Resistant Stenoses........................................ 183
3.4 Stenting of Dialysis Fistulae and Grafts............................... 183
3.5 Central Venous Stenosis in Dialysis Patients....................... 184
3.6 Management of Thrombosed Dialysis
Grafts and Fistulae ................................................................ 184
3.7 Complications of Dialysis Fistula
and Graft Interventions ......................................................... 186
4 Conclusion ............................................................................ 186
References...................................................................................... 186
Abstract
The long-term maintenance of haemodialysis access via
funnelled lines or fistulas is challenging. The insertion
of dialysis lines and the management of subsequent
complications of these catheters by interventional radiol-
ogy will be discussed. A range of endovascular techniques
for the presentation of haemodialysis fistula access will
also be reviewed.
1 Introduction
The aim of this chapter is to review the prominent role of
the interventional radiologist in the multidisciplinary man-
agement of haemodialysis vascularaccess. This encompasses
the placement and management of haemodialysis catheters
and a range of percutaneous procedures to deal with the
complications of grafts and fistulae. The interventional radi-
ologist is anintegralpart of thedialysis team withan ability to
provide significant benefits in preserving vascular access.
2 Dialysis Line Insertion
and Management
2.1 Dialysis Line Insertion
Temporary, non-tunnelled haemodialysis catheters are for
short-term haemodialysis, which is between several days
and a few weeks, duration. Short-term haemodialysis line
insertion has a low complication rate and is usually carried
out by non-radiologists.
Long-term haemodialysis catheters are tunnelled through
a short subcutaneous route between the skin and the site of
venous puncture. Tunnelled dialysis lines are recommended
by the American National Kidney Foundation clinical
guidelines (National Kidney Foundation 2001) in patients
requiring temporary venous access for periods greater than
J. R. Asquith (&)
University Hospital of North Staffordshire NHS Trust,
Newcastle Road, Stoke-on-Trent, ST4 6QG, UK
e-mail: john.asquith@uhns.nhs.uk
M. G. Cowling (ed.), Vascular Interventional Radiology, Medical Radiology. Diagnostic Imaging,
DOI: 10.1007/174_2012_567, Ó Springer-Verlag Berlin Heidelberg 2012
179
https://t.me/med1917
3 weeks. At the skin exit site of tunnelled lines a cuff
reduces infection rates and decreases the inadvertent
removal of tunnelled catheters compared to non-tunnelled
catheters (Flowers et al. 1989; Maki et al. 1988).
Tunnelled lines can provide good haemodialysis access for
many months. They are particularly useful during the matu-
ration of a fistula or graft, which may take up to 3 months
before dialysis is possible. Tunnelled catheters are also used
‘permanently’ when all other access routes for fistula forma-
tion have been exhausted. In addition many patients present
late to renal units with end-stage renal failure and hence tun-
nelled catheters are often required until definitive dialysis
access is available (Chesser and Baker 1997). The disadvan-
tages of tunnelled lines compared to native fistulae include the
risk of infection, development ofvenous stenosis or occlusion,
which is often central, and the presence of the external lines.
Traditionally tunnelled dialysis lines were inserted
without imaging guidance. However, line placement using
ultrasound and fluoroscopy has been shown to produce
better results than using anatomical landmarks alone.
Ultrasound provides a greater puncture success rate with
fewer complications than blind insertion (Mallory et al.
1990; Lameris et al. 1990; Forauer and Glockner 2000).
Published series show lower rates of primary line malpo-
sition, fewer complications and less catheter infections with
radiological placement when compared to blind insertion
(McBride et al. 1997; Trerotola et al. 1997).
There are numeroustypesof tunnelled dialysiscatheters in
use. They include the Tesio system of two separate single-
lumen 10F silastic catheters, which produce higher flow
rates than the older dual lumen step-tip designs of catheters
(Prabhu et al. 1997). The main disadvantage of Tesio lines is
the requirement for two separate tunnels (Tesio et al. 1994).
It was initially anticipated that twin catheters would have a
longer survival rate than the dual lumen devices, but there is
evidence that this is not the case (Caridi et al. 1999). An
alternative is the Ash Split 14.5 F catheter which has two
independent lumens and hence the theoretical advantages of
twin catheters,butonly requiresa singlesubcutaneous tunnel.
2.2 Choice of Vein for Access: Conventional
Central Veins
There are several venous access sites for tunnelled line
insertion including the internal jugular and subclavian veins.
Subclavian lines have a higher incidence of procedural
complications when compared to internal jugular lines,
including subsequent venous thrombosis and stenosis
(Cimochowski etal. 1990;Schillinger et al. 1991;Macdonald
et al. 2000; Trerotola et al. 2000). With subclavian line-
induced venous stenosis thereis also thepossible exclusion of
use of the ipsilateral extremity for future fistula formation.
Therefore, the subclavian approach should be avoided
wherever possible. The right internal jugular vein should be
used preferentially, followed by the left internal jugular vein.
This is because right-sided insertion is technically more
straightforward and right-sided internal jugular venous
catheters cause stenosis less frequently than left-sided cath-
eters (Salgadoet al. 2004).The internal jugular vein puncture
should be low in the neck (approximately 2 cm above the
clavicle), which facilitates tunnelling by avoiding the ster-
nocleidomastoid muscle (Silberzweig and Mitty 1998) and
reduces the risk of kinking due to formation ofan acute angle
in the line which can be associated with higher punctures.
2.3 Optimal Catheter Position
The optimal position for the tip of a dialysis catheter is in
the region of the superior vena cava-right atrial junction
(National Kidney Foundation 2001). If the catheter is
positioned too low in the right atrium there is the risk of
perforation of the right atrial wall and arrhythmias. During
catheter positioning it is also important to realise that due to
traction on the catheter in the subcutaneous tissues the tip of
the catheter will move cephalad by approximately 3 cm
when the patient moves from the supine to the upright
position (Nazarian et al. 1997; Kowalski et al. 1997).
A routine, post procedural chest radiograph is not required
for lines inserted using imaging guidance because malpo-
sition and complications are rare (Gladwin et al. 1999;
Chang et al. 1998).
2.4 Alternative Dialysis Line Access Routes
Alternative routes have been described for when both the
internal jugular and subclavian veins are unavailable for
line insertion. These approaches include femoral veins,
neck collaterals (Funaki et al. 2001), external jugular veins
(Forauer et al. 2000), the translumbar inferior vena cava
(Markowitz et al. 1998; Rajan et al. 1998) and percutaneous
hepatic veins (Po et al. 1994; Duncan et al. 1995). The
femoral vein has a slightly higher risk of infection (Zaleski
et al. 1999) and a substantially shorter primary catheter
patency rate when compared to the internal jugular veins
(Maya and Allon 2005). A further potentially useful tech-
nique is venous recanalization of occluded veins for central
venous catheter placement (Funaki et al. 2001; Haller et al.
2009). When recanalization of central veins using conven-
tional techniques fails, then ‘sharp’ recanalization has been
described as an alternative. Sharp recanalization uses the
stiff end of an hydrophilic wire or an intravascular needle to
traverse the occlusion and hence allow insertion of the
dialysis catheter (Athreya et al. 2009).
180 J. R. Asquith
https://t.me/med1917
2.5 Fibrin Sheath Formation
Dialysis lines usually fail due to the formation of a peri-
catheter fibrin sheath or intracatheter thrombosis (Crain
et al. 1996; Trerotola et al. 1997). The clinical signs of fibrin
sheath formation include poor flow and an inability to
aspirate blood through the catheter. A fibrin sheath can be
detected by performing a linogram, which will demonstrate
contrast being retained around the tip of the line and
backtracking around it (Fig. 1a).
The treatment options for fibrin sheath formation include
thrombolytic infusions, line stripping, catheter exchange or
line replacement. Stripping of a fibrin sheath is performed
by capturing the end of the dialysis line with a gooseneck
snare and repeatedly pulling the tightened snare down over
the end of the line to remove the fibrin (Fig. 1) (Crain et al.
1996). Findings from a randomised study show that line
stripping and urokinase infusion are equivalent in immedi-
ate restoration of catheter function and maintenance of
long-term patency (Gray et al. 2000). This study would
suggest that thrombolytic infusion is preferable to stripping
because it is non-invasive, cheaper to perform, administered
on the dialysis unit, preferred by patients and safer. Another
randomised trial has shown longer patency rates with line
exchange compared to stripping for the treatment of fibrin
sheath formation (Merport et al. 2000). However, when
retrospectively compared by another centre (Janne d’Othee
et al. 2006) durability of catheter function was equivalent
between the techniques of line stripping and line exchange.
Therefore, it is clear that catheter exchange or line stripping
should be reserved for those patients in whom thrombolytic
infusions have failed. With conflicting evidence when
deciding on whether to strip or exchange a failing line, then
consideration regarding cost and patient preference should
also be made.
2.6 Catheter Repositioning
The radiologist can assist in repositioning catheters that
have become misplaced into the contralateral brachioce-
phalic vein due to either spontaneous migration of the
catheter tip or primary misplacement during insertion
without fluoroscopic guidance. A transfemoral approach is
usually used to reposition central lines. The repositioning is
performed by dragging the line down with a pigtail catheter
or by grabbing the tip of the line with a gooseneck snare
(Hartnell et al. 1996; Boardman and Hughes 1998).
Radiological repositioning of lines is quick, simple to per-
form and avoids replacement of the line.
Fig. 1 a Twin Tesio catheters placed via a left common femoral vein
approach. Linogram shows contrast is retained around the catheters
due to fibrin sheath formation (arrow). Urokinase infusion produced
no improvement; b line stripping was performed using a gooseneck
type snare with a left internal jugular vein approach; c the final image
shows contrast flowing freely from the catheter side holes
Dialysis Access Management 181
https://t.me/med1917
3 Management of Dialysis Fistulae
and Grafts
3.1 Imaging of Dialysis Fistulae and Grafts
The commonest indications for fistula and graft imaging are
poor flows, high venous pressures during dialysis and fail-
ure to mature. The main imaging investigations are Doppler
ultrasound and digital subtraction angiography (DSA). DSA
remains the mainstay of fistula imaging, because it is quick,
easy to perform, depicts the entire length of the venous
return and can be followed immediately by an interven-
tional procedure. However, ultrasound plays an important
initial role in assessing problematic fistulae and allows
planning of the more invasive investigation of DSA.
Comparative studies have shown that Doppler ultrasound
and DSA correlate well (Chandra et al. 2010).
The optimal approach for performing a diagnostic fis-
tulogram depends upon the clinical indication. When there
is delayed maturation the arterial inflow and the arteriove-
nous anastomosis should be studied and this can be per-
formed by retrograde puncture of the ipsilateral brachial
artery at the elbow. When there is hand ischaemia due to
steal syndrome, then subclavian arterial catheterisation from
the femoral route allows complete visualisation of the upper
limb arteries and the entire venous outflow. If the indication
is poor flows or high venous pressures, then a retrograde
puncture of the venous side of the fistula allows demon-
stration of the arteriovenous anastomosis and the entire
length of the venous return..
Pullback pressure gradient measurement from the SVC
to the arterial anastomosis may be helpful when no signif-
icant stenosis is identified on the angiogram despite
abnormality with dialysis. Pressure measurements may also
be useful as an adjunct to angiography for identifying
venous stenoses persisting after apparently successful
angioplasty (Funaki et al. 2002).
Carbon dioxide gas has been used as an alternative to
iodinated contrast for angiography of the venous side of a
fistula. This is particularly useful in patients who have not
yet used their fistula for dialysis and where avoidance of
nephrotoxic contrast is desirable in an effort to preserve
residual renal function. However, carbon dioxide must be
used with caution due to the risk of reflux into the cerebral
circulation when being used to study the arterial anasto-
mosis (Ehrman et al. 1994; Spinosa et al. 1998; Kariya et al.
2010). Gadolinium has also been used as an alternative to
iodinated contrast for catheter fistulagrams (Spinosa et al.
1998; Sancak et al. 2002) and contrast enhanced MRA has
been used as an alternative to invasive fistulography.
However the risk of nephrogenic systemic fibrosis has now
largely prevented these applications.
Doppler ultrasound is an accurate technique for the
detection of problems in fistulae and grafts (Finlay et al.
1993; Bacchini et al. 2000). A major limitation with ultra-
sound is the difficulty in detecting central venous stenoses.
Doppler ultrasound has also been successfully used as a
guide to angioplasty and stenting in arterio-venous access in
order to avoid nephrotoxic contrast. This technique is par-
ticularly useful in patients not yet on dialysis or in those
who are allergic to contrast media (Marks et al. 2007).
3.2 Angioplasty of Dialysis Fistulae
and Grafts
The first radiological reports of angioplasty in grafts and
native fistulae were published in the early 1980s (Gordon
et al. 1982; Hunter et al. 1984). Currently, dilation of
stenoses greater than 50% with an associated clinical or
haemodynamic abnormality is recommended by the clinical
practice guidelines of the American National Kidney
Foundation (National Kidney Foundation 2001). Angio-
plasty of these significant stenoses reduces the thrombosis
risk and increases the longevity of the access (Turmel-
Rodrigues et al. 2000a; Manninen et al. 2001). Angioplasty
has a low complication rate, may be performed on an out-
patient basis and dialysis can resume immediately.
An antegrade approach should be used for stenoses
located away from the arterial anastomosis and a retrograde
approach for stenoses close to the arterial anastomosis. The
diameter of the angioplasty balloon should be equal to or
1 mm greater than the diameter of the adjacent normal
vessel or graft. Unless the vessel is unusually small then 6 to
8 mm diameter balloons are used in both grafts and native
fistulae. It has been shown that 55% of stenoses require
pressures greater than 15 atmospheres to eliminate the waist
on the balloon. Very high angioplasty pressures of greater
than 20 atmospheres are needed to adequately treat 20% of
stenoses in native fistulae and 9% in grafts (Trerotola et al.
2005).
Stenoses frequently recur relatively rapidly and patency
rates depend on the type of access being treated and
on the location of the stenosis. Technical success for angio-
plasty is usually defined as a less than 30% residual diameter
stenosis. Several series for angioplasty in native upper limb
fistulae have shown a very good technical success rate of
90–97%. However, currently the Achilles heel of fistula
angioplasty is restenosis with a 12-month primary patency of
26–64%. With further intervention a secondary patency rate
of 81–90% can be achieved at 1 year (Lay et al. 1998;
Turmel-rodrigues et al. 2000a; Manninen et al. 2001; Clark
et al. 2002; Maeda et al. 2005; Asif et al. 2006). Similarly,
several large series in grafts show angioplasty has a high
clinical success rate of up to 98%, but with a primary patency
182 J. R. Asquith
https://t.me/med1917
rate of 17–44% at 1 year. After a year secondary patency
rates of 92% can be achieved in grafts (Kanterman et al.
1995; Aruny et al. 1999; Beathard 1992; Safa et al. 1996).
As a result of the disappointing results of restenosis after
angioplasty in fistulae there has been some enthusiasm for
the potential benefit of drug-eluting balloons in order to
reduce fistula restenosis rates. This has followed on from
the promising early experience in lower limb arteries
(Werk et al. 2008; Tepe et al. 2008; Schmidt et al. 2011).
Paclitaxel eluting balloons may help to inhibit neo-intimal
hyperplasia and hence reduce the re-stenosis rates. How-
ever, the role of drug eluting balloons needs to be further
investigated with randomised trials.
3.3 Angioplasty of Resistant Stenoses
Some fistula and graft stenoses are resistant to balloon
angioplasty using standard pressure balloons. These resis-
tant lesions have been treated with high pressure balloons,
for example, the Bard Conquest balloon that has a rated
burst pressure of 30 atm. Use of the Conquest balloon, with
ultra high pressures of up to 40 atm, has also been advo-
cated (Trerotola et al. 2004). With these very high pressures
a high technical success rate of 100% was achieved, which
is comparable to cutting balloon angioplasty.
Use of the cutting balloon to treat resistant haemodialysis
stenoses was first described in the mid 1990s (Vorwerk
et al. 1995a, 1996a). The blades of a cutting balloon produce
microincisions allowing controlled intimal disruption
(Fig. 2). Cutting balloons can achieve high technical success
rates of 95–100% in treating resistant stenoses in fistulae and
grafts (Vorwerk et al 1996a; Song et al. 2004; Bhat et al.
2007). In the series by Song et al. there were 2 ruptures in 8
cases of native fistulae, but one of these was located
at the cephalic arch, which is notorious for complications
(Turmel-Rodrigues et al. 2000a). In a recent, but relatively
small, randomised trial of cutting balloon angioplasty versus
ultrahigh-pressure angioplasty in native fistulae the two
techniques had equivalent immediate results (Kundu et al.
2010). A second, but retrospective, comparative study of
cutting balloon versus high-pressure balloon used in native
fistulae to treat stenoses resistant to conventional angioplasty
showed that both techniques were effective. In the cutting
balloon group there was some evidence of a more long-
standing primary patency rate at 6 month follow-up (Wu
et al. 2008). In summary, current evidence suggests that
cutting balloons may play an important role in treating
resistant stenoses, but there is only limited information
regarding long-term patency rates, safety and cost effective-
ness when compared to ultra high pressure balloons.
3.4 Stenting of Dialysis Fistulae and Grafts
There has been considerable interest in the stenting of fis-
tulae and grafts, but randomised trials have not shown
significant advantages of bare-stents over angioplasty in
Fig. 2 a The arterial
anastomosis of this forearm loop
graft has already been
unsuccessfully angioplastied
using a conventional balloon.
Cutting balloon angioplasty was
therefore performed to treat the
resistant stenosis (arrow); b the
final fistulagram after cutting
balloon angioplasty shows no
residual stenosis
Dialysis Access Management 183
https://t.me/med1917
recurrent venous stenosis (Hoffer et al. 1997; Quinn et al.
1995; Beathard 1993). Primary patency rates of only 47
and 20% at 6 months and 1 year, respectively were obtained
in one study for a small subgroup of native fistulae
(Turmel-Rodrigues et al. 1997a). Most studies with stenting
suggest the need for close follow-up and multiple secondary
interventions to maintain patency. Therefore, in native fistu-
lae, stents are generally only used selectively to treat com-
plications and when angioplasty fails to maintain patency,
particularly in patients who are unsuitable for surgical revi-
sion (Turmel-Rodrigues et al. 1997a; Pan et al. 2004).
The situation is different for prosthetic haemodialysis
grafts. A recent prospective randomised trial (Haskal et al.
2010) has shown greater patency rates for the treatment of
venous anastomotic stenoses with the use of stent grafts
compared to conventional balloon angioplasty.
Covered stents have also been advocated for the treat-
ment of pseudoaneurysms of dialysis access grafts and fis-
tulae (Fig. 3). A large pseudoaneurysm can cause difficulty
with needling and be unsightly for the patient. Traditionally,
large pseudoaneurysms have been dealt with surgically.
Small series have been published in which covered stents
have salvaged dialysis grafts and fistulae (Ryan et al. 2003;
Hausegger et al. 1998). In these reports concern about
pseudoaneurysm recurrence and infection have divided
opinion as to whether the stent can subsequently be needled.
3.5 Central Venous Stenosis in Dialysis
Patients
Haemodialysis patients are at particular risk for the devel-
opment of central venous stenosis or thrombosis and much
of this is due to multiple central venous catheterisations
(Cimochowski et al. 1990). Central venous stenoses are
associated with clinical symptoms such as arm swelling
or functional impairment of haemodialysis. Central veins
respond relatively poorly to angioplasty with a 23–29%
primary patency rate at 6 months (Beathard 1992; Quinn
et al. 1995). Published data and opinion regarding stenting
of central venous stenosis are divided. Some authors rec-
ommend stents in central veins (Mickley et al. 1997; Haage
et al. 1999; Vorwerk et al. 1995b) whereas others claim no
advantage of stenting over angioplasty (Quinn et al. 1995;
Bakken et al. 2007). Stent placement for central venous
stenosis refractory to angioplasty has excellent initial
technical results (Fig. 4), but variable 1-year primary
patency rates ranging from 25 to 70% (Haage et al. 1999;
Vesely et al. 1997; Mickley et al. 1997). In the subclavian
vein there is concern about early stent failure caused by
positional compression, which can result in stent fracture
(Maleux et al. 1998; Maintz et al. 2001). More encourag-
ingly, a retrospective study (Vogel and Parise 2004) sug-
gests that nitinol stents can be used in central venous
stenoses with improved patency rates. If a stent is used it
should not overlap and hence exclude adjacent veins from
future access use. In summary, angioplasty should be the
preferred treatment in central venous stenosis with stent
placement reserved for failed angioplasty or recurrence of a
stenosis within a 3-month period (Aruny et al. 1999). It is
also clear that multiple additional interventions are required
to maintain patency with either angioplasty or stenting for
central venous stenoses. Larger randomised studies are still
needed to clarify the role of stents, particularly with the
newer nitinol stents.
3.6 Management of Thrombosed Dialysis
Grafts and Fistulae
Acute graft or native fistula thrombosis should ideally be
avoided by use of screening. Monitoring with flow mea-
surements, clinical examination or Doppler ultrasound can
help by allowing the earlier detection and angioplasty of
Fig. 3 a The arterial and venous sides of this forearm loop graft developed large false aneurysms at the needling sites; b both false aneurysms
were successfully excluded using Viabahn stent grafts (Gore, Flagstaff, CA)
184 J. R. Asquith
https://t.me/med1917